Formoterol Fumarate

This page contains recent news articles, when available, and an overview of Formoterol Fumarate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Formoterol Fumarate
(when available)

Pharmacology and use:
Not Available For maintenance treatment of asthma in patients 6 years of age and older with reversible obstructive airways disease, including patients with symptoms of nocturnal asthma, who are using optimal corticosteroid treatment and experiencing regular or frequent

Mechanism Of Action:
Not Available

News Articles on Formoterol

Pearl Therapeutics Announces Positive Results From Phase 2a Trial of ...  -  ‎Jan 4, 2010‎
Formoterol fumarate is a well-known, established, long-acting beta2 agonist (LABA) bronchodilator that is indicated for the management of asthma and COPD ... PR Newswire (press release)

Mundipharma Successfully Completes European Late-Stage Program for ...  -  ‎Nov 2, 2009‎
Flutiform is a fixed-dose combination of fluticasone propionate and formoterol fumarate and is administered using a metered-dose inhaler. ... Genetic Engineering News (press release)

Schering-Plough Reports Financial Results for 2009 Third Quarter  -  ‎Oct 22, 2009‎
...a fixed-dose combination of mometasone furoate and formoterol fumarate, for the maintenance treatment of asthma in patients 12 years of age and older. ... Reuters

Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32  -  ‎Oct 29, 2009‎
Perforomist® Solution, Dey's Formoterol Fumarate Inhalation Solution (Perforomist Solution), and Dey's EpiPen® Auto-Injector (EpiPen Auto-Injector), ... Reuters

CHEST: COPD Treatment Determines Risk of Hospitalization  -  ‎Nov 6, 2009‎
...salmeterol/fluticasone propionate (Advair), formoterol fumarate (Foradil, Perforomist), salmeterol (Serevent), or combination therapy. ... MedPage Today

… for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution...  -  May 21, 2007
..."Safety Profile of Formoterol Fumarate Delivered by Nebulization to COPD ... The formoterol fumarate molecule has been used worldwide for more than two ... Free with registration - PR Newswire - AccessMyLibrary.com

Press Release: Nebulized Formoterol Fumarate Has Comparable …  -  May 20, 2008
Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution...  -  May 21, 2007
Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Study: Significantly Improved Bronchodilation & Symptom Control with ...  -  May 20, 2008
..."Efficacy and Safety of Formoterol Fumarate Delivered by Nebulization to COPD ... Formoterol fumarate is a rapid and long-acting beta2-agonist (LABA) that ... newswise.com

… for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution...  -  May 20, 2007
Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… Use of Nebulized Formoterol Fumarate and Tiotropium Provides …  -  May 20, 2008
Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over ... Pay-Per-View - PR Newswire - HighBeam Research

… : Two Clinical Trials for Nebulized Formoterol Fumarate on Long...  -  Oct 24, 2007
Two Clinical Trials for Nebulized Formoterol Fumarate on Long-Term and Cardiovascular Safety in Treating COPD. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… Treatment With Nebulized Formoterol Fumarate and Tiotropium...  -  May 20, 2008
Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

… Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment...  -  Oct 24, 2007
The only commercially available version of nebulized formoterol fumarate is ... Formoterol fumarate is a rapid and long-acting beta2-agonist (LABA) that has ... Free with registration - PR Newswire - AccessMyLibrary.com

mometasone furoate + formoterol fumarate Novartis phase change I,...  -  May 30, 2005
...mometasone furoate + formoterol fumarate, formoterol fumarate + mometasone furoate, R3F, Antiasthmatic, B2-Stimulants with Corticoids, Novartis, phase-I, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

Allergy & Immunology; Formoterol fumarate inhalation powder for...  -  Jul 19, 2005
2005 JUL 19 - (NewsRx.com) -- SkyePharma PLC (SKP) announced that the German pharmaceutical regulatory authority has approved Foradil Certihaler (formoterol ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

… Dey, LP's Perforomist(TM) (Formoterol Fumarate) Inhalation...  -  May 12, 2007
..."The first nebulized formoterol fumarate, Perforomist(TM) Inhalation Solution offers a new treatment option to COPD patients," said Nicholas J. Gross, MD, ... Medical News Today - Medical News Today (press release)

Press Release: Clinical Trial Data for Perforomist(TM) Inhalation...  -  May 16, 2008
Article: Nebulized Formoterol Fumarate Has Comparable ... PR Newswire; May 20, ... Article: Concomitant Use of Nebulized Formoterol Fumarate ... ... Pay-Per-View - PR Newswire - HighBeam Research

… Therapeutics and Dey, LP Launch Perforomist(TM) (Formoterol...  -  Oct 8, 2007
Critical Therapeutics, Inc. (Nasdaq: CRTX) today announced that the Company has commercially launched Perforomist[TM] (formoterol fumarate) Inhalation ... Free with registration - Business Wire - AccessMyLibrary.com

… Dey, LP's Perforomist(TM) (Formoterol Fumarate) Inhalation...  -  May 11, 2007
FDA Approves Dey, LP's Perforomist(TM) (Formoterol Fumarate) Inhalation Solution for Maintenance Treatment of COPD. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

International Approvals: Foradil, Oncophage, Multiferon  -  Jun 27, 2005
On June 9, Germany's Ministry of Health approved a formoterol fumarate dry ... Formoterol fumarate powder is currently available in the US as a capsule for ... Medscape

Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged …  -  Oct 29, 2008
It is the only FDA-approved nebulized formoterol fumarate. Results from "In COPD, Nebulized Formoterol Fumarate Provides Prolonged Bronchodilation and ... International Business Times

Press Release: AstraZeneca Responds to FDA Joint Advisory …  -  Dec 12, 2008
SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) is approved in over 100 countries for the long-term maintenance treatment of asthma and is available ... Pay-Per-View - PR Newswire - HighBeam Research

Novartis and Schering-Plough announce collaboration to develop novel ...  -  Aug 14, 2006
In April 2003, the companies announced an agreement to jointly develop and market worldwide a novel therapy combining Foradil (formoterol fumarate) with ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com

FDA approves new inhalable COPD treatment  -  May 15, 2007
The market's first nebulized form of formoterol fumarate for chronic obstructive pulmonary disease (COPD) has been given the go ahead by the US Food and ... In-PharmaTechnologist.com

Press Release: Get SMART: Symbicort gives patients the power to...  -  Jan 11, 2006
AstraZeneca announced today that SYMBICORT(R) (budesonide/formoterol fumarate ... NEM033 ) Administered twice daily, SYMBICORT is a combination of two ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: Approved Asthma Therapy SYMBICORT Improves Lung …  -  Nov 13, 2006
13 /PRNewswire-FirstCall/ -- Newly presented data indicate that treatment with SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) inhalation aerosol ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Study Analyzed SYMBICORT(R) in Children with …  -  May 20, 2008
AstraZeneca announced today that SYMBICORT(R) (budesonide/formoterol fumarate ... NEM033 ) Administered twice daily, SYMBICORT is a combination of two ... Pay-Per-View - PR Newswire - HighBeam Research

AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA …  -  Aug 21, 2006
AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA approval for Symbicort (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol. $4.95 - Drug Topics - ECNext

Clinical Trial Data For Perforomist Inhalation Solution Presented At ...  -  May 23, 2007
..."Safety Profile of Formoterol Fumarate Delivered by Nebulization to COPD ... The formoterol fumarate molecule has been used worldwide for more than two ... Medical News Today - Medical News Today (press release)

Chronic obstructive pulmonary disease.(DRUG UPDATE)  -  May 1, 2005
No data have shown similar risks in COPD patients. formoterol fumarate Onset of action is 15 minutes with sustained inhalation powder (12-hour) ... Free with registration - Internal Medicine News - AccessMyLibrary.com

AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA …  -  Aug 21, 2006
AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA approval for Symbicort (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol. ... $9.94 - Drug Topics - Alacra Store

… Trial Data on the Safety and Efficacy of Concomitant Formoterol...  -  Oct 24, 2007
The only commercially available version of nebulized formoterol fumarate is ... Formoterol fumarate is a rapid and long-acting beta2-agonist (LABA) that has ... Pay-Per-View - PR Newswire - HighBeam Research

Significant Improvements Shown In Concomitant Use Of Perforomist & …  -  May 21, 2008
It is the only FDA-approved nebulized formoterol fumarate. Donald P. Tashkin, MD, FACP, FCCP, Professor of Medicine, David Geffen School of Medicine at the ... Medical News Today - Medical News Today (press release)

Novartis And Schering-Plough Collaboration To Develop Novel Once- …  -  Aug 20, 2006
In April 2003, the companies announced an agreement to jointly develop and market worldwide a novel therapy combining Foradil (formoterol fumarate) with ... Medical News Today - Medical News Today (press release)

Press Release: Mylan's Dey LP Announces Establishment of 'J-Code' for...  -  Nov 6, 2008
Article: FDA Approves Dey, L.P.'s Perforomist(TM) (Formoterol Fumarate) ... ... Perforomist(TM) (formoterol fumarate) Inhalation Solution for long-term, ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: PARI Respiratory's LC PLUS & PRONEB Ultra Deliver …  -  Oct 9, 2007
Perforomist (formoterol fumarate) Inhalation Solution is indicated for ... Formoterol fumarate is a rapid, long-acting beta(2)-agonist (LABA) that has been ... Pay-Per-View - PR Newswire - HighBeam Research

Article: Chronic obstructive pulmonary disease.(Drug Update) - Skin &...  -  May 1, 2005
No data have shown similar risks in COPD patients. formoterol fumarate Onset of action is 15 minutes with inhalation powder sustained (12-hour) ... Pay-Per-View - Skin & Allergy News - HighBeam Research

AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA …  -  Aug 21, 2006
AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA approval for Symbicort (budesonide/ formoterol fumarate dihydrate) Inhalation Aerosol. ... Free with registration - Drug Topics - AccessMyLibrary.com

Chronic obstructive pulmonary disease.(DRUG UPDATE) | Article from …  -  May 1, 2005
No data have shown similar risks in COPD patients. formoterol fumarate Onset of action is 15 minutes with sustained inhalation powder (12-hour) ... Pay-Per-View - Internal Medicine News - HighBeam Research

Press Release: AstraZeneca Submits an sNDA for SYMBICORT(R) for …  -  Apr 30, 2008
Anglo-Swedish drug major AstraZeneca's Symbicort (budesonide/formoterol fumarate dihydrate ... trials, which evaluated over 3600 COPD patients and had ... Pay-Per-View - PR Newswire - HighBeam Research

Chronic obstructive pulmonary disease.(Drug Update) | Article from …  -  May 1, 2005
No data have shown similar risks in COPD patients. formoterol fumarate Onset of action is 15 minutes with sustained inhalation powder (12-hour) ... Pay-Per-View - Family Practice News - HighBeam Research

COPD Patients Breathe Easier with Combo Therapy  -  Oct 29, 2007
Nebulized formoterol fumarate is currently available in Perforomist™ Inhalation Solution, a medication made by Dey, LP. “For the patients in this study, ... Ivanhoe Broadcast News

Press Release: Pivotal Data Showed SYMBICORT(R) Improved Lung …  -  Oct 29, 2008
New study results showed that AstraZeneca's Symbicort (budesonide/formoterol fumarate ... Proceedings, examined two doses of Symbicort, including twice its ... Pay-Per-View - PR Newswire - HighBeam Research

Formoterol Inhalation Solution.(PRODUCTS)(Brief article)  -  Aug 1, 2007
It is the first FDA-approved nebulized formoterol fumarate; the drug is already available in the United States in a dry powder formulation. ... $4.95 - Internal Medicine News - ECNext

… , Dey, LP, Announces that Perforomist(TM) (Formoterol Fumarate) …  -  Oct 8, 2007
Mylan Inc. Subsidiary, Dey, LP, Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: New Data on Perforomist(TM) Inhalation Solution to be ...  -  Oct 24, 2008
..."In this COPD study, nebulized formoterol fumarate provided prolonged bronchodilation and increased patient perception of their disease control compared to ... Pay-Per-View - PR Newswire - HighBeam Research

FDA approves Dey, LP's NDA for chronic obstructive pulmonary disease ...  -  May 15, 2007
...“The first nebulized formoterol fumarate, Perforomist Inhalation Solution offers a new treatment option to COPD patients,� said Nicholas J. Gross, MD, PhD, ... News-Medical.net

Article: Foradil Certihaler, Celebrex.(New & Approved) - Family...  -  Feb 15, 2007
New & Approved) ... find Family Practice News articles. Foradil Certihaler (formoterol fumarate inhalation powder, Novartis Pharmaceuticals) The Food and... Pay-Per-View - Family Practice News - HighBeam Research

Article: Study supports cardiovascular safety profile of naproxen.(OT...  -  Dec 18, 2006
Article: Two Clinical Trials for Nebulized Formoterol Fumarate on ... PR Newswire; October 24, 2007 ; 700+ words ... ... scientific assembly of the American ... Pay-Per-View - Chain Drug Review - HighBeam Research

Press Release: Clinical Trial Data for Perforomist(TM) Inhalation...  -  May 16, 2007
Data from Phase III pivotal trial demonstrate safety and efficacy of first FDA-approved nebulized formoterol fumarate for patients with moderate to severe ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Data from Three Clinical Trials for Perforomist(TM) …  -  Oct 16, 2007
Presentations on long-term safety and cardiovascular safety of nebulized formoterol fumarate and safety/ efficacy of concomitant use with tiotropium for ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Drug Combo Improves Survival in Patients With COPD. - ...  -  Oct 23, 2006
Article: Two Clinical Trials for Nebulized Formoterol Fumarate on . ... Formoterol fumarate is ... of Nebulized Formoterol in COPD: An Open-Label Active . ... Pay-Per-View - PR Newswire - HighBeam Research

Allergists Respond to FDA Committee Recommendation on Asthma …  -  Dec 11, 2008
...salmeterol) and Symbicort (budesonide/formoterol fumarate dihydrate) but said ... (formoterol fumarate) should no longer be used for treating asthma. ... International Business Times

Fast-acting agent for long-term maintenance of asthma.(News: DRUG …  -  Jan 1, 2008
Active ingredients: Budesonide 160mcg, formoterol fumarate dihydrate 4.5mcg; per inh; pressurized metered-dose inhaler. Also: SYMBICORT 80/4.5 Rx ... Free with registration - McKnight's Long-Term Care News - AccessMyLibrary.com

Critical Therapeutics and Dey, LP Complete Definitive Co-Promotion …  -  Jun 28, 2007
Perforomist is the first and only FDA-approved nebulized formoterol fumarate. Nebulizers convert liquid medication into a mist that patients inhale through ... Free with registration - Business Wire - AccessMyLibrary.com

Presentation Of Clinical Trial Data For Perforomist Inhalation...  -  May 17, 2007
..."Safety Profile of Formoterol Fumarate Delivered by Nebulization to COPD Patients," Poster Board #A11, Publ. pg. A128. Session Info: Thematic Poster Session ... Medical News Today - Medical News Today (press release)

ASVP, CRTX, TCNH, UGTH, CPNE "Red Hot Penny Stock Alert".  -  May 14, 2007
Perforomist(TM) Inhalation Solution is the first and only FDA-approved nebulized formoterol fumarate. Nebulizers convert liquid medication into a mist that ... Free with registration - M2 Presswire - AccessMyLibrary.com

Nebulizer Formulation of Formoterol Approved  -  May 22, 2007
May 22, 2007 (San Francisco) -- Earlier this month, the US Food and Drug Administration (FDA) approved formoterol fumarate inhalation solution (FFIS, ... Medscape

International Approvals: Symbicort SMART, Alimta, Xyrem  -  Mar 19, 2007
On March 6, Health Canada approved budesonide plus formoterol fumarate dehydrate inhalation aerosol ( Symbicort Maintenance and Reliever Therapy [SMART ] ... Medscape

New Data on Perforomist(TM) Inhalation Solution to Be Presented at …  -  Oct 24, 2008
..."In this COPD study, nebulized formoterol fumarate provided prolonged bronchodilation and increased patient perception of their disease control compared to ... RedOrbit

Allergists Respond To FDA Committee Recommendation On Asthma …  -  Dec 15, 2008
...salmeterol) and Symbicort (budesonide/formoterol fumarate dihydrate) but said ... (formoterol fumarate) should no longer be used for treating asthma. ... Medical News Today - Medical News Today (press release)

CRLD, CRTX, NAWL, KDKN - OTCStockExchange.com Stock Alert.  -  May 14, 2007
Perforomist(TM) Inhalation Solution is the first and only FDA-approved nebulized formoterol fumarate. Nebulizers convert liquid medication into a mist that ... Free with registration - M2 Presswire - AccessMyLibrary.com

Speak with other shareholders about: (OTCBB: TCNH), (NASD: CRTX), ( …  -  May 15, 2007
PerforomistTM Inhalation Solution is the first and only FDA-approved nebulized formoterol fumarate. Nebulizers convert liquid medication into a mist that ... Free with registration - M2 Presswire - AccessMyLibrary.com

AstraZeneca asthma drug receives FDA approval  -  Jul 23, 2006
Symbicort combines budesonide and formoterol fumarate dihydrate. It is inhaled as an aerosol. Budesonide is an inhaled corticosteroid and provides an ... USA Today

Press Release: Critical Therapeutics Perforomist Inhalation Soulution...  -  May 14, 2007
Perforomist(TM) Inhalation Solution is the first and only FDA-approved nebulized formoterol fumarate. Nebulizers convert liquid medication into a mist that ... Pay-Per-View - M2 Presswire - HighBeam Research

National Survey Confirms Asthma Awareness 'Gap'.  -  Oct 25, 2007
SYMBICORT (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol is a controller medicine for the long-term maintenance of asthma for people 12 years ... $4.95 - PR Newswire - ECNext

Press Release: Critical Therapeutics and Dey, LP Complete Definitive...  -  Jun 28, 2007
Perforomist is the first and only FDA-approved nebulized formoterol fumarate. Nebulizers convert liquid medication into a mist that patients inhale through ... Pay-Per-View - M2 Presswire - HighBeam Research

Alerts: Turning Pennies into dollars: (OTCBB: TCNH), (NASD: CRTX), ( …  -  May 16, 2007
PerforomistTM Inhalation Solution is the first and only FDA-approved nebulized formoterol fumarate. Nebulizers convert liquid medication into a mist that ... $4.95 - M2 Presswire - ECNext

Press Release: Study Analyzed Long-Term SYMBICORT(R) Use in …  -  Mar 17, 2008
AstraZeneca announced today that SYMBICORT(R) (budesonide/formoterol fumarate ... NEM033 ) Administered twice daily, SYMBICORT is a combination of two ... Pay-Per-View - PR Newswire - HighBeam Research

Formoterol Inhalation Solution.(PRODUCTS)(Brief article) | Article...  -  Aug 1, 2007
It is the first FDA-approved nebulized formoterol fumarate; the drug is already available in the United States in a dry powder formulation. ... Pay-Per-View - Internal Medicine News - HighBeam Research

FDA Has Public Health Advisory on Inhaled Long-acting Bronchodilator ...  -  Nov 18, 2005
The three drugs are Advair Diskus (fluticasone propionate & salmeterol inhalation powder), Foradil Aerolizer (formoterol fumarate inhalation powder), ... DG News

Foradil Certihaler Approved for Treating Asthma  -  Dec 19, 2006
The FDA has approved SkyePharma's Foradil Certihaler (formoterol fumarate inhalation powder) for the treatment of asthma. The FDA issued an approvable ... Facts and Comparisons

Combo Asthma Treatment Brings Symptom Relief  -  May 22, 2007
Symbicort -- a combination of the inhaled corticosteroid budesonide and the long-acting beta agonist, formoterol fumarate dehydrate -- was recently approved ... ABC News

Advair's Growth Could Be Hurt by FDA Labeling Proposal, Analysts Say  -  Nov 22, 2005
...the public health advisory were GSK's Serevent (salmeterol xinafoate inhalation powder) and Novartis' Foradil (formoterol fumarate inhalation powder). ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones

Article: Asthma inhaler approved in US - The Record (Bergen County,...  -  Jul 22, 2006
Symbicort combines budesonide and formoterol fumarate dihydrate. It is inhaled as an aerosol. Budesonide is an inhaled corticosteroid and provides an ... Pay-Per-View - The Record - HighBeam Research

Advair, Symbicort Get Advisory Panel Support for Asthma  -  Dec 15, 2008
The committees also weighed in on AstraZeneca's Symbicort (budesonide/formoterol fumarate), voting 26–0 with one abstention that the product's benefits ... FDA news - FDA news (subscription)

SkyePharma Announces FORADIL(R) CERTIHALER(TM) Launched in …  -  Sep 7, 2005
...(formoterol fumarate inhalation powder) on the German market for the treatment of asthma and chronic obstructive pulmonary disease (COPD). ... RedOrbit

FDA warns of long-acting bronchodilator risks.(Rx)  -  Dec 15, 2005
The three products that are available in the United States are formoterol fumarate inhalation powder (Foradil) and salmeterol xinafoate inhalation powder ... Free with registration - Internal Medicine News - AccessMyLibrary.com

Long-acting [[beta].sub.2]-agonists in asthma: safety concerns.(Health...  -  Oct 25, 2005
The drugs: LABAs sold in Canada include salmeterol (as Serevent and,in combination with fluticasone, as Advair) and formoterol fumarate (as Oxeze and ... Free with registration - CMAJ: Canadian Medical Association... - AccessMyLibrary.com

Approved Asthma Therapy SYMBICORT Improves Lung Function Safely …  -  Nov 14, 2006
Newly presented data indicate that treatment with SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) inhalation aerosol results in significantly ... Medical News Today - Medical News Today (press release)

Budesonide/Formoterol Inhalation Therapy Improves Lung Function in …  -  Oct 31, 2008
Pennsylvania) — Two large pivotal trials, the6-month SHINE and the 1-year SUN trials, show that budesonide/formoterol fumarate dihydrate (Symbicort, ... Medscape

Pivotal Data Showed SYMBICORT(R) Improved Lung Function in Adults …  -  Oct 29, 2008
...demonstrated that SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol significantly improved lung function and was well-tolerated ... RedOrbit

Clinical trials conducted in area  -  Jun 3, 2007
The purpose of the study is to determine the appropriate dose of a drug called fluticasone propionate/formoterol fumarate in patients with chronic ... North County Times

Study Analyzed SYMBICORT(R) in Children With Persistent Asthma  -  May 20, 2008
SYMBICORT(R) (budesonide/formoterol fumarate dehydrate) Inhalation Aerosol(2) in treating mild to moderate persistent asthma in children ages 6 to 15 ... RedOrbit

AstraZeneca PLC (AZN) Submits an sNDA for SYMBICORT(R) for the …  -  Jun 4, 2008
...indication for SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the long-term maintenance treatment of asthma in pediatric ... Lifescience-online

Editorials - July 15, 2006 -- American Family Physician  -  Jul 15, 2006
...inhalation powder), Advair Diskus (fluticasone propionate and salmeterol inhalation powder), Foradil Aerolizer (formoterol fumarate inhalation powder). ... AAFP News Now

Study Analyzed SYMBICORT In Children With Persistent Asthma  -  May 23, 2008
A new 12-week study examined safety and efficacy measures of the maintenance combination asthma therapy, SYMBICORT (budesonide/formoterol fumarate ... emaxhealth.com

AstraZeneca Announces SYMBICORT(R) is Now Available in the US  -  Jun 25, 2007
WILMINGTON, Del., June 25 /PRNewswire-FirstCall/ -- AstraZeneca announced today that SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) pressurized ... RedOrbit

USA policy: FDA divided on safety of Serevent and Foradil  -  Dec 10, 2008
...(fluticasone propionate/salmeterol) and Swiss drug major Novartis' Foradil (formoterol fumarate), which is marketed by local firm Schering-Plough. ... $34.00 - EIU Country Analysis - Alacra Store

Asthma Drugs Should Remain on Market, But Foradil Needs Black Box, …  -  Jul 15, 2005
...bronchodilators -- Novartis' Foradil (formoterol fumarate inhalation powder) and GlaxoSmithKline's (GSK) Advair (fluticasone propionate/salmeterol) and ... Pay-Per-View - Drug Industry Daily - Factiva, from Dow Jones

Significant asthma control and improved lung function with Symbicort  -  Feb 24, 2007
New data demonstrated the maintenance combination asthma therapy, SYMBICORT (budesonide/formoterol fumarate dehydrate), provides a rapid, ... emaxhealth.com

Data Show Significant Asthma Control and Improved Lung Function with ...  -  Mar 2, 2007
New data demonstrated that the maintenance combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dehydrate), provides a rapid, ... news Stories

AstraZeneca Announces SYMBICORT Is Now Available In The US  -  Jun 29, 2007
AstraZeneca has announced that SYMBICORT® (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler (pMDI) is now available in the United ... Medical News Today - Medical News Today (press release)

SYMBICORT Improves Lung Function  -  Nov 27, 2006
Newly presented data indicate that treatment with SYMBICORT® (budesonide/formoterol fumarate dihydrate) inhalation aerosol results in significantly greater ... news Stories

Improved Quality Of Life And Patient Satisfaction With SYMBICORT  -  May 24, 2007
New data demonstrated that the combination asthma therapy, SYMBICORT® (budesonide/formoterol fumarate dihydrate), led to significant improvements in ... Medical News Today - Medical News Today (press release)

Skyepharma PLC announces Trading Update  -  Jul 8, 2008
The product incorporates a fast onset long-acting beta-agonist (formoterol fumarate) with the most commonly prescribed inhaled anti-inflammatory ... marketwire.com

Critical Therapeutics Announces Change in Management  -  Mar 4, 2008
...for Perforomist(TM) (formoterol fumarate) Inhalation Solution (Perforomist); our ability to successfully enter into additional strategic co-promotion, ... Lifescience-online

Data from Three Clinical Trials for Perforomist(TM) Inhalation...  -  Oct 16, 2007
Perforomist(TM) Inhalation Solution is the first and only FDA-approved nebulized form of formoterol fumarate and is indicated for long-term, twice- daily ... Free with registration - PR Newswire - AccessMyLibrary.com

Critical Therapeutics Completes Phase II Clinical Trial for Zileuton ...  -  Jun 2, 2008
...the success of our co-promotion arrangement with DEY for Perforomist(TM) (formoterol fumarate) Inhalation Solution; our ability to successfully enter ... RedOrbit

The 340B Prime Vendor Program Adds AstraZeneca's Asthma Drug …  -  Sep 27, 2007
...announced today that SYMBICORT® (budesonide/formoterol fumarate dihydrate) pressurized metered dose inhaler (pMDI) is now available to PVP participants ... marketwire.com

Critical Therapeutics Reports Financial Results for the Three and...  -  Sep 30, 2007
Began promoting PerforomistTM (formoterol fumarate) Inhalation Solution, DEY's product for the long-term maintenance treatment of Chronic Obstructive ... RedOrbit

GSK Criticizes FDA's Proposed Labeling for Advair, Serevent  -  Nov 28, 2005
...inhalation powder); and Novartis' Foradil (formoterol fumarate inhalation powder), all of which treat asthma by relaxing the muscles around the airways in ... Pay-Per-View - Washington Drug Letter - Factiva, from Dow Jones

FDA advisory issued for three bronchodilators.(News)  -  Jun 1, 2006
...both made by GlaxoSmithKline Inc. Foradil Aerolizer (formoterol fumarate), made by Novartis AG, is included in the health advisory. ... Free with registration - Pediatric News - AccessMyLibrary.com

Keeping an Eye on Rising Biotech Firms  -  Apr 1, 2007
In December, the FDA approved SkyePharma's Foradil® Certihaler™ (formoterol fumarate inhalation powder) for the treatment of asthma. ... Genetic Engineering News - Genetic Engineering News (press release)

Brand Names/Synonyms:
Formoterol Fumarate is also known by the following brand names and/or synonymsCHEMBANK1706; FORMOTEROL FUMARATE; Foradil; Formoterol; Formoterol [Usan:Inn]; Formoterolum [Inn-Latin]; Oxeze; Oxeze Turbuhaler; Oxeze Turbuhaler Foradil

Drug Category:
Formoterol Fumarate is categorized under the following by the FDA: Bronchodilator Agents; Sympathomimetic; ATC:R03AC13

Dosage Forms:
METERED-DOSE (AEROSOL);POWDER

Absorption:
Not Available

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
N-[2-hydroxy-5-[1-hydroxy-2-[2-(4-methoxyphenyl)-1-methyl-ethyl]amino-ethyl]-phenyl]methanamide





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy